New England Science Symposium - NESS
The 21st Annual New England Science Symposium (NESS) will take place virtually on Friday, April 29, and Saturday, April, 30, 2022.
Abstract submission period is now closed. Registration information to attend the event will be available in March.
Attendees will be able to attend the keynote address, oral presentation, review students’ abstracts and have networking opportunities on the virtual platform.
Please note that the Facilitated Research Discussions will be closed break-out sessions between presenters and judges.
Follow us on twitter: @NESS_News
The New England Science Symposium (NESS), established in 2002, provides a forum for postdoctoral fellows; medical, dental and graduate students; post-baccalaureates; college and community college students (particularly for African-American, Hispanic/Latino and American Indian/Alaska Native individuals) to share their biomedical and health-related research activities through oral or poster presentations, to engage in discussions related to career development in the sciences, to exchange ideas and to expand their professional networks.
Levi Garraway, M.D., Ph.D.
Executive Vice President
Head of Global Product Development
Chief Medical Officer
Abstract submission deadline has passed.
Registration for the general public in now open. Please register using the link below.
If you have any questions or concerns, please email Rodolfo Ramos at firstname.lastname@example.org
PRESENTATION RESOURCES (Videos)
- Introduction on the Beginning Stages of Creating a Poster
- Getting Started on Creating a Poster (Format, Templates and Softwares)
- Transferring Your Abstract into a Poster (Step by Step Guide)
- How to Present Your Poster and Practice Your Presentation
- Poster Presentation Outline (Summary)
Awards for outstanding oral and poster presentations in various disciplines and categories are: Ruth and William Silen, M.D. Awards, Dana-Farber/Harvard Cancer Center Awards, Postdoctoral Awards, Beth Israel Deaconess Medical Center Department of Neonatology Award, TACS BIO Stem Cell and Regenerative Medicine Award, American Cancer Society Awards, and Predicine Translational Research Award.
Harvard Medical School
Minority Faculty Development Program (MFDP)
The Minority Faculty Development Program (Established 1990) of the Office for Diversity Inclusion and Community Partnership (Established 2002; originally named Faculty Development and Diversity) sponsors programs for the development of Harvard Medical School faculty and trainees, with an emphasis on mentoring and leadership, as well as programs that are designed to reach out to the pre-college, college, graduate and postdoctoral populations with the goal of bringing outstanding students from groups underrepresented in medicine into the biomedical science pipeline.
BSCP was founded in 1991 by MFDP in collaboration with the Massachusetts Medical Society and the New England Board of Higher Education to identify, inform, support and provide mentoring for academically outstanding minority students and fellows ranging from high school to postdoctoral level.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.